SILO Silo Pharma, Inc.
Pharmaceutical Preparations · Nasdaq · SEC CIK 1514183 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-50.0%
TTM net income YoY26.7%
TTM EPS YoY159.8%
Revenue 3-yr CAGR-20.6%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-12,534.1%
Net margin-10,319.0%
FCF margin—
EBITDA margin—
Returns
ROE-55.3%
ROA-49.0%
ROIC (approx.)-207.1%
Asset turnover0.00x
Leverage & solvency
Liabilities / assets4.0%
Debt / equity0.00x
Current ratio24.43x
Interest coverage-112.82x
Cash quality & payout
Operating cash flow / net income0.80x
Accruals ratio-9.6%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $72,102 | $72,102 |
| Cost of revenue | $44,295 | $5,838 |
| Gross profit | $27,807 | $66,264 |
| R&D expense | $2.16M | $2.37M |
| Operating income | -$4.28M | -$4.71M |
| Interest expense | $37,302 | $5,084 |
| Pretax income | -$4.23M | -$4.39M |
| Net income | -$4.23M | -$4.39M |
| EPS (basic) | -0.50 | -1.19 |
| EPS (diluted) | -0.50 | -1.19 |
| Weighted avg. shares (diluted) | 8.38M | 3.68M |
| Balance sheet | ||
| Cash & equivalents | $4.75M | $3.91M |
| Short-term investments | $2.11M | $3.17M |
| Current assets | $7.39M | $7.11M |
| Intangibles | $217,375 | $241,215 |
| Total assets | $7.61M | $7.41M |
| Current liabilities | $650,183 | $1.66M |
| Total liabilities | $1.30M | $2.38M |
| Shareholders' equity | $6.31M | $5.03M |
| Shares outstanding | 887,886 | 4.48M |
| Cash flow statement | ||
| Operating cash flow | -$4.66M | -$3.83M |
| Investing cash flow | $644,021 | $973,777 |
| Financing cash flow | $4.86M | $3.24M |
| Stock-based compensation | $117,021 | $0 |
Free plan shows the latest 2 periods; Pro shows all 12 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.